Wallace J L, Chin B C
Intestinal Disease Research Unit, Faculty of Medicine, University of Calgary, Alberta, Canada.
Proc Soc Exp Biol Med. 1997 Mar;214(3):192-203. doi: 10.3181/00379727-214-44087.
Irrespective of where ulceration occurs in the gastrointestinal tract, it is almost always associated with mucosal inflammation. The chemical mediators that coordinate inflammatory responses also have the capability to alter the resistance of the mucosa to injury. Some inflammatory mediators increase the resistance of the mucosa to injury, while others exert "ulcerogenic" effects. In this review, we provide an overview of the major inflammatory mediators that have been shown to exert effects on mucosal defense in the gastrointestinal tract. Among the inflammatory mediators discussed are the eicosanoids (prostaglandins, leukotrienes, thromboxanes), nitric oxide, neuropeptides, and cytokines (IL-1beta, TNF alpha). Several of these mediators are considered potential therapeutic targets for the treatment of ulcerative diseases of the digestive system, and, in some cases, clinical data are available on the efficacy of such approaches.
无论胃肠道溃疡发生在何处,几乎总是与黏膜炎症相关。协调炎症反应的化学介质也有能力改变黏膜对损伤的抵抗力。一些炎症介质可增加黏膜对损伤的抵抗力,而其他一些则具有“致溃疡”作用。在本综述中,我们概述了已被证明对胃肠道黏膜防御有影响的主要炎症介质。所讨论的炎症介质包括类二十烷酸(前列腺素、白三烯、血栓素)、一氧化氮、神经肽和细胞因子(IL-1β、TNF-α)。其中几种介质被认为是治疗消化系统溃疡性疾病的潜在治疗靶点,并且在某些情况下,已有关于此类方法疗效的临床数据。